Allstate India empowers women with valuable job skills and equipment in 2nd year of Project Nirmiti
Beneficiaries were honored during 2nd Valedictorian Ceremony, reaffirming Allstate India's commitment to…
Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in Combination with Palbociclib and Endocrine Therapy at the 2024 San Antonio Breast Cancer Symposium
December 11, 2024 07:05 ET | Source: Celcuity Inc. Median overall survival…
Ocugen CEO to Present at Oppenheimer Movers in Rare Disease Summit
MALVERN, Pa., Dec. 11, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or…
GEn1E Lifesciences appoints Franois Nader, MD as Chair of its Board of Directors
Former CEO of NPS Pharma brings strong biotech expertise to further accelerate…
PureTech Founded Entity Seaport Therapeutics Presents Additional Data from Phase 1 Study of SPT-300 at ACNP Annual Meeting 2024
Multiple well-tolerated doses with pharmacodynamic activity were identified and will be included…
Veradermics Raises $75 Million in Series B Financing and Initiates Phase 2/3 Trial for Hair Loss
Investment to fund pivotal trials of VDPHL01, an oral investigational medicine for…
Seaport Therapeutics Presents Additional Data from Phase 1 Study of SPT-300 at ACNP Annual Meeting 2024
Multiple well-tolerated doses with pharmacodynamic activity were identified and will be included…
IMUNON Announces Continued Strong Improvement in Overall Survival Data from Randomized Phase 2 OVATION 2 Study of IMNN-001
Based on more than six months of additional monitoring, data show continued…
Artelo Biosciences Announces Presentation of Phase 1 Data with ART27.13 in Cancer-Related Anorexia
Phase 1 data from the CAReS trial showed an attractive safety profile…
Movement Network Foundation Announces Launch of Movement Mainnet Beta and $MOVE Token Generation Event
GRAND CAYMAN, Cayman Islands, Dec. 9, 2024 /PRNewswire/ -- The Movement Network…